December 2011 Volume 7, Issue 12
Volume 7, Issue 12 | December 2011
December 2011
In this Issue
Research & Development

Plug-and-play deal
Acute-care therapy developer Cubist Pharmaceuticals to acquire pain management specialist Adolor in deal valued at up to $415 million
Making a spark, igniting a fire
Michael J. Fox Foundation partners with Kinetics Foundation in search of biomarker in Parkinson’s disease
Two heads are better than one
California’s stem cell agency joins forces with NIH to advance stem cell research
Another brick in the wall
NeoStem closes acquisition of Amorcyte, another step in its drive toward cell therapy focus
Done deal times two
ViroPharma agrees to buy DuoCort Pharma weeks before its orphan drug Plenadren is granted European Marketing Authorization for adrenal insufficiencyContract Services

Doing some corporate stock-up shopping
Seeking to fill gaps and extend reach, Quintiles acquires three companies in October and November
WuXi buys in its backyard
CRO purchases two China-based clinical research services companies
Injecting strength into the business
Germany’s Evonik buys SurModics Pharmaceuticals to bolster North America presence
Repligen acquires Novozymes Biopharma
Company strengthens position as supplier of products for manufacturing biologic drugs; expects near-term, sustainable profitability
Design, make, test
U.K.’s Sygnature Discovery, Saretius launch strategic alliance aimed at treating CNS disorders, inflammatory diseasesOmics & Systems Biology

Getting to the heart of the matter
Servier, miRagen team up on cardiovascular disease therapeutics
A high-'Profile' partnership
Dana-Farber, Brigham and Women's undertake genomics research project
A gram better way to do things
Powerful SomaLogic proteomic technology to be applied to biomarker discovery, target discovery and validation and lead to ‘wellness’ chip
Start spreading the news
New York Genome Center launches collaboration of 11 leading medical/research institutions
Adding tools to the toolbox
Horizon, Promega forge predictive disease model pactDiagnostics

Being 'companionable' with new immunotherapy
Life Technologies signs agreement with GlaxoSmithKline Biologicals, seeking expanded use of platform technologies into companion diagnostics
A full work-up for Alzheimer’s disease
Exonhit taps Cleveland Clinic’s Lou Ruvo Center to conduct AclarusDx test for early diagnosis of Alzheimer’s disease
Pancreatic cancer biomarkers sought
Oxford Gene Technology and Abcodia combine expertise to search for better biomarkers for the early diagnosis of pancreatic cancer
Your halo is showing
Sweden's Halo Genomics and Uppsala University collaborate on study to identify mutations that cause colon cancerGlobal News

Taking direct action
Roche makes $230 million offer for antiviral developer Anadys; shareholders challenge the offer in court
Bomb meets bomber in new deal
Oxford BioMedica takes glaucoma research from Mayo Clinic to explosive new level with agreement to develop gene therapy
Cancer deaths in Korea
Institut Pasteur Korea and Sanofi look for small-molecule antiviral to combat HBV
Not ‘immune’ to each other’s charm
Biogen, Portola ink agreement for autoimmune therapeutics
Two against the flu
Alios BioPharma and Versitech Ltd. announce exclusive worldwide licensing agreement for influenza technologyCommentary

Data management that speeds—rather than impedes—advanced DNA sequencing applications
How labs choose to manage their data may very well determine which have the most success in applying DNA sequencing to the development of advanced molecular diagnostics and therapeutics.
On biobanking: Deposits and withdrawals
It is encouraging to see the challenge of well-documented samples being met using electronic medical records to make queries more feasible and less costly.Editor's Focus

Out with the old, in with many new features to ddn
It’s difficult to believe we’re about to put our final issue of 2011 to press, but as we don our gay apparel, pour some celebratory eggnog and give this edition a final polish, we have a rare few moments to pause and reflect on another editorial year gone by.Instruments & Informatics

Taking a new pathway
Caliper, Pfizer launch platform for drug safety
Going 'Broad' to get specific about cancer
Affymetrix announces cancer-profiling collaboration with the Broad Institute to advance The Cancer Genome Atlas
One assay, 242 genes
RainDance Technologies and Ambry Genetics launch new DNA sequencing panel for ADME research
Finding satisfaction in stratification
Selventa and Linguamatics announce strategic partnership to provide a ‘complete pipeline’ of scientific knowledge extraction to their life science partnersSpecial Reports

The personal side of cell biology
For personalized medicine to truly arrive, cell biology may be more important in the end than genomics

Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
Subscribe